
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Sandy Sargis is a senior research associate in early-stage purification at Genentech, Inc.
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Published: March 2nd 2009 | Updated: